IMA
ImageneBio, Inc.
Key Financials
Operating Income
$-48451000
↑ 17.8%
Net Income
$-45349000
↑ 7.9%
Revenue
$800000
↓ 77.1%
EPS (Diluted)
$-9.64
↓ 845.1%
Total Assets
$153.0M
↑ 8.1%
Total Liabilities
$19.8M
↑ 27.4%
Shareholders' Equity
$133.1M
↑ 5.7%
Operating Cash Flow
$-47844000.00
↓ 4.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| EFFECT | 8/11/2026 | View on SEC |
| EFFECT | 8/11/2026 | View on SEC |
| EFFECT | 8/6/2026 | View on SEC |
| S-8 | 8/5/2026 | View on SEC |
| S-3 | 8/5/2026 | View on SEC |
| POS AM | 8/5/2026 | View on SEC |
| 424B3 | 8/5/2026 | View on SEC |
| S-3 | 8/5/2026 | View on SEC |
| 10-Q | 8/5/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | IMA |
| Company Name | ImageneBio, Inc. |
| CIK | 1835579 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 857-343-8292 |